- Home
- AEC vs ALPS Comparison
AEC vs ALPS Comparison
Compare AEC & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AEC | ALPS |
|---|---|---|
| Founded | 1989 | 2017 |
| Country | Canada | Malaysia |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.0M | 66.6M |
| IPO Year | 2011 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AEC | ALPS |
|---|---|---|
| Price | $3.09 | $0.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 38.8K | 27.5K |
| Earning Date | 05-01-2015 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.70 | $0.23 |
| 52 Week High | $10.24 | $1.72 |
Technical Indicators
Market Signals| Indicator | AEC | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 30.16 |
| Support Level | $2.80 | $0.23 |
| Resistance Level | $5.11 | $0.44 |
| Average True Range (ATR) | 0.19 | 0.01 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 71.67 | 0.20 |
Price Performance
Historical ComparisonAbout AEC Anfield Energy Inc.
Anfield Energy Inc is a mineral exploration and development company. This company focuses on uranium and vanadium development and near-term production. The exploration project of the company includes Shootaring Canyon Mill and Velvet-Wood and Slick Rock Uranium Project from Uranium One and The West Slope Project located in Montrose and San Miguel Counties in southwestern Colorado. The company's geographical segments are Canada and the United States.
About ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.